MARKET

EOLS

EOLS

Evolus
NASDAQ
4.300
+0.020
+0.47%
After Hours: 4.470 +0.17 +3.95% 18:24 02/13 EST
OPEN
4.290
PREV CLOSE
4.280
HIGH
4.495
LOW
4.285
VOLUME
465.45K
TURNOVER
--
52 WEEK HIGH
17.12
52 WEEK LOW
4.091
MARKET CAP
278.73M
P/E (TTM)
-4.7128
1D
5D
1M
3M
1Y
5Y
1D
Evolus Grants Stock Awards to New Hires Under 2023 Inducement Plan
Reuters · 8h ago
EVOLUS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 8h ago
Weekly Report: what happened at EOLS last week (0202-0206)?
Weekly Report · 4d ago
Analysts Are Bullish on These Healthcare Stocks: Evolus (EOLS), Upstream Bio, Inc. (UPB)
TipRanks · 02/03 21:50
Evolus Price Target Cut to $13.00/Share From $20.00 by HC Wainwright & Co.
Dow Jones · 02/03 12:24
Evolus Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 02/03 12:24
HC Wainwright & Co. Maintains Buy on Evolus, Lowers Price Target to $13
Benzinga · 02/03 12:16
Evolus: Market Share Gains, Strategic Filler Expansion, and Attractive Valuation Support Buy Rating Despite Guidance Reset
TipRanks · 02/03 11:27
More
About EOLS
Evolus, Inc. is a performance beauty company. Its primary market is the cash-pay aesthetic market, which consists of medical products. Its product candidates represent two of the product categories within medical aesthetics, injectable neurotoxins and injectable hyaluronic acid gels. Its product candidates include Jeuveau and Evolysse. Jeuveau is its commercially available proprietary 900 kilodalton (kDa), purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Jeuveau offers a 900kDa botulinum toxin alternative to BOTOX (onabotulinumtoxinA). Jeuveau is available in the United States, Canada, and certain European markets. Evolysse is a line of hyaluronic acid dermal fillers which utilizes first-generation cold technology. The line includes a variety of products, including mid face, nasolabial folds, lips and eyes in the United States and Europe.

Webull offers Evolus Inc stock information, including NASDAQ: EOLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EOLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EOLS stock methods without spending real money on the virtual paper trading platform.